Peer Review History
| Original SubmissionMay 2, 2023 |
|---|
|
PONE-D-23-13229Rational social distancing in epidemics with uncertain vaccination timingPLOS ONE Dear Dr. Schnyder, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 23 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Jan Rychtář Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This work was supported by the Grants-in-Aid for Scientific Research (JSPS KAKENHI) under Grants No. 17K17825 (JJM), 20H00129 (RY), 20K03786 (JJM), 224 20H05619 (RY), 22H04841 (SKS), the JSPS Core-to-Core Program “Advanced core-to-core network for the physics of self-organizing active matter” (all of us), and the SPIRITS 2020 grant of Kyoto University (JJM). MST acknowledges the generous support of visiting fellowships from JSPS Fellowship, ID L19547, and the Leverhulme Trust, Ref. IAF-2019-019, and the kind hospitality of the Yamamoto group." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "This work was supported by the Grants-in-Aid for Scientific Research (JSPS 221 KAKENHI) under Grants No. 17K17825 (JJM), 20H00129 (RY), 20K03786 (JJM), 222 20H05619 (RY), 22H04841 (SKS) and the SPIRITS 2020 grant of Kyoto University 223 (JJM). MST acknowledges the generous support of visiting fellowships from JSPS 224 Fellowship, ID L19547, and the Leverhulme Trust, Ref. IAF-2019-019, and the kind 225 hospitality of the Yamamoto group. Websites: JSPS: https://www.jsps.go.jp/english/ Leverhulme Trust: https://www.leverhulme.ac.uk/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability. "Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized. Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access. We will update your Data Availability statement to reflect the information you provide in your cover letter. 4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. Additional Editor Comments: The manuscript has been reviewed by two reviewers and myself. Both reviewers and myself see a value in the manuscript. The reviewers make several suggestions which I encourage the authors to incorporate in their revision. The manuscript has been reviewed by two reviewers and myself. Both reviewers and myself see a value in the manuscript. The reviewers make several suggestions which I encourage the authors to incorporate in their revision. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This work seems nice and informative, which is fairly underpinned by a solid theoretical ground. The authors were interested in an individuals’ optimal decision making that is affected by the bulk transmission rate considering their attitude whether social-distancing somehow being accounted or ignored, which is substantially influenced by the timing of when a perfect vaccination is introduced (denoted by t_v), from when all remained S individuals would be immediately transferred to R. They adopted a standard SIR process, and established behavior model concerning Kappa(t). Subsequently, going thru formulating Hamiltonian, the authors drew Nash Equilibrium on behaver; Eq. (13). This is the case of the timing of vaccination; t_v, regarded as deterministic. In contrast to this, the authors explored the corresponding Kappa, when the timing of t_v being stochastic; Eq. (30). They deliver quite interesting and intelligible numerical results to capture what their model has contribute; for instance, Fig. 4. With surging an outbreak of I(t), people withhold their activity by reducing the control; k, to minimize the risk of infection. And following to that, if there is none of introducing vaccination (grey dotted), people tend to back to normal in a rapid manner, which inevitably brings a large amount of infected people. Let alone, if people know the exact timing of vaccination without any uncertainty, behavior; k, immediately resumes to the level of pre-outbreak, and infected individuals die out. The cases with uncertainty let people behave deliberately, staying at highly social-distancing (smeller k). As a whole, the results seem quite likely. In sum, I favor their approach, seemed scientifically robust, and the presented result is impressive. Hence, I positively evaluate the work. I would like to give a technical question as below. As abovementioned, they presumed that a vaccination makes all S individuals to be R in a moment. Which is quite ideal, or say rather unrealistic as an assumption. I’ve fully understood that the authors intended to be only concerned on the timing of vaccination as a stochastic element (bringing uncertainty) not from other elements. Yet, anyone can agree that the efficacy of vaccination is unequivocally imperfect. By either the so-called Effectiveness or Efficiency idea, the uncertainty of vaccination should be accounted. They should discuss on this point, and are expected to deliver the case considering the uncertainty of vaccine efficacy. They should reference to the concept of Effectiveness and Efficiency for a vaccination with citing relevant literatures; for instance, (i) Sociophysics Approach to Epidemics, Springer, 2021. Reviewer #2: I can evaluate this work can be published on PLOSE. Yet, to improve the contents ensuring more impressive information to the audience of PLOSE one, I would like to give following point to be revised in the final MS. ##1. The current form of introduction part is too narrow, some related works are not considered here. Authors can read intervention game related works by following some previous researches: How quarantine and social distancing policy can suppress the outbreak of novel coronavirus in developing or under poverty level countries: a mathematical and statistical analysis, Biometrics & Biostatistics International Journal. How Evolutionary Game Could Solve the Human Vaccine Dilemma, Chaos, Solitons & Fractals 152, 111459 (2021). Social distancing as a public-good dilemma for socio-economic cost: An evolutionary game approach, Heliyon, Heliyon 8, e11497 (2022). A cyclic epidemic vaccination model: Embedding the attitude of individuals toward vaccination into SVIS dynamics through social interactions, Physica A, 581, 126230 (2021). ##2. I could not find any substantial discussion that can fully reflect the assumption of PGG model setup (for example pairwise game). Is it possible to express current model by using pairwise (two by two) evolutionary game mode? Please also mention clearly about all formulation and parameter settings including assumed values that can be fully understandable. (Equation 2) Also, in equation (1), why is there no recover rate or say (recovery rate=1)? Please explain. I also found some gaps between epidemic model, optimal control model and game model. Author should clearly explore these there different model in the same platform that audience can understood. ##3. The results seem less impressive and insufficient. I think, it will be very meaningful if authors plot some 2D phase diagram varying two parameters. By introducing 2D heatmap can be explore details explanation of current works. ##4. Is dilemma is evolving in this works? If there is some dilemma than please read the following some previous research works and try to introduce here. Dilemma strength as a framework for advancing evolutionary game theory: “Universal scaling for the dilemma strength in evolutionary games”, Physics of Life Reviews 14, 56-58, 2015. Social efficiency deficit deciphers social dilemmas, scientific reports (Nature), 10, 16092 (2020). Tanimoto; Evolutionary Games with Sociophysics: Analysis of Traffic Flow and Epidemics, Springer, 2019. Modelling and analysing the coexistence of dual dilemmas in the proactive vaccination game and retroactive treatment game in epidemic viral dynamics, Proceedings of the Royal Society A 475, 20190484, (2019). ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Rational social distancing in epidemics with uncertain vaccination timing PONE-D-23-13229R1 Dear Dr. Schnyder, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Jan Rychtář Academic Editor PLOS ONE Additional Editor Comments (optional): Both reviewers were happy with the revisions and the paper is now acceptable for publication. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I did give several suggestions in the process. This version seems enough to be accepted to the journal... Reviewer #2: This paper is well written, authors addressed all comments properly that seems correct; the work is acceptable. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-23-13229R1 Rational social distancing in epidemics with uncertain vaccination timing Dear Dr. Schnyder: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Jan Rychtář Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .